Stockreport

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]

Immunome, Inc.  (IMNM) 
PDF first-in-class and best-in-class targeted cancer therapies, announced today that on December 2, 2024, the Compensation Committee of the Company's Board of Directors (the [Read more]